Travere Therapeutics Inc
NASDAQ:TVTX
| Market Cap (Intraday) | 1.47B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $23.52 |
| 50-Day MA | $18.65 |
| 200-Day MA | $22.18 |
Travere Therapeutics Inc Stock, NASDAQ:TVTX
3611 Valley Centre Drive, Suite 300, San Diego, California 92130
United States of America
Phone: +1.888.969.7879
Number of Employees: 262
Description
Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. The firm's products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 8, 2008 and is headquartered in San Diego, CA.